SCHEMBL12366308

SCHEMBL12366308

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccc(F)cc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.43
NR1H2 P55055 2/20 0.43
NR1H3 Q13133 2/20 0.43
CNR1 P21554 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
DCTPP1 Q9H773 1/20 0.39
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 4/20 0.38
USP2 O75604 2/20 0.38
CYP1A2 P05177 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366238 0.93 DCTPP1 (0.42) RXRANR1H2NR1H3CNR1DCTPP1
SCHEMBL12366212 0.93 CNR1 (0.44) RXRANR1H2NR1H3CNR1DCTPP1
SCHEMBL12366275 0.91 CFTR (0.42) RXRANR1H2NR1H3CNR1DCTPP1
SCHEMBL12366320 0.91 KDM4E (0.47) RXRANR1H2NR1H3CNR1CYP11B1
SCHEMBL12366245 0.90 CNR1 (0.43) RXRANR1H2NR1H3CNR1DCTPP1
SCHEMBL12366313 0.90 CNR1 (0.38) RXRANR1H2NR1H3CNR1CYP11B1
SCHEMBL12366396 0.89 RXRA (0.41) RXRANR1H2NR1H3CNR1HPGD
SCHEMBL12366421 0.89 RXRA (0.39) RXRANR1H2NR1H3CNR1DCTPP1
SCHEMBL12366330 0.88 RGS4 (0.41) RXRANR1H2NR1H3CYP11B1CYP11B2
SCHEMBL12366376 0.88 RXRA (0.40) RXRACNR1DCTPP1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed